ONSTRYV DIN 02484668
Status: Marketed
Holder: VALEO PHARMA INC
Molecule: SAFINAMIDE (SAFINAMIDE MESYLATE)
Available to quote
Health Canada record
| Active ingredient(s) | SAFINAMIDE (SAFINAMIDE MESYLATE) 100 MG |
|---|---|
| Dosage form | Tablet |
| Route | Oral |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | N04BD03 SAFINAMIDE |
| Original market date | 08-Jul-2019 |
| Current status date | 08-Jul-2019 |
| Source | Health Canada DPD |
Establishment licence of the holder
Valeo Pharma Inc — licence 101116, currently licensed, last inspection rating C (2026-06-09).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing SAFINAMIDE (SAFINAMIDE MESYLATE)
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02484641 | ONSTRYV | VALEO PHARMA INC | Tablet | SAFINAMIDE (SAFINAMIDE MESYLATE) 50 MG | Marketed |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 21720 | 2019-01-10 | New Drug Submission (NDS) |